The Pathology department's Selective Surgical Pathology Fellowship offers surgical pathology training with special emphasis on the pathology of neoplastic diseases.
About the Program
The Selective Surgical Pathology Fellowship meets the requirements for the fifth year of training in pathology. A large volume of material provides an unusual opportunity for in-depth experience and the development of proficiency in the diagnosis of neoplastic diseases. In addition to all subspecialties of surgical pathology and autopsy services, rotations are available in electron microscopy, immunohistochemistry, flow cytometry, molecular diagnostic and various research laboratories.
All fellows are required to conduct an investigative study under the supervision of staff pathologists. An elective period is also provided. Participation in intra- and interdepartmental conferences is emphasized. Because of the specialized and demanding nature of the material encountered, the program is best suited for the individual who has already obtained a good background in general anatomic pathology.
To be considered for an interview, a file must be started before March 1 of the year prior to the intended fellowship, which begins July 1.
Candidates for the Selective Surgical Pathology Fellowship must be board certified or eligible for certification in anatomic pathology or AP/CP.
Please check complete GME Eligibility Requirements prior to applying.
A completed application must be received by August 31 (22 months prior to the start of the training year). After this deadline, applications will be reviewed on an as-needed basis.
Commensurate with the candidate's level of training
Victor Prieto, M.D., Ph.D.
UT MD Anderson Cancer Center
1515 Holcombe Blvd.
Pathology Fellowship, Box 085
Houston, TX 77030-4095
For inquiries, please contact:
Kareen E. Chin
For inquiries of elective rotations, please email:
For inquiries of observerships, please email:
Verification of training
Requests for verification should be sent to:
MD Anderson Cancer Center is committed to encouraging good health and staying true to our mission to end cancer. If you are applying for a GME fellowship or residency program starting on or after July 1, 2016, please be advised that MD Anderson will have instituted a tobacco-free hiring process as part of its efforts to achieve these goals. If you are offered an appointment, you will be subject to a Pre-Employment Drug Screen for tobacco compounds in compliance with applicable state laws. If you do not pass the urine drug screening which includes testing for tobacco compounds, you CANNOT be appointed at MD Anderson. Should you fail to meet this contingency, MD Anderson will withdraw your offer of appointment for the academic year. You may reapply for the following academic year, but there are no guarantees that you will be offered a position as many of our programs are already filled for several years out.